Skip to content
Peptilyze

Analysis · Reference article

What is looksmaxxing? Origin, risks and what the evidence says

A neutral explainer of looksmaxxing: where the term comes from, the range from skincare to surgery to unapproved drugs, and what clinicians and regulators say.

Published · Updated · Rests on: 1 qualitative study of 8,072 forum comments, 1 cross-sectional social-media analysis, 2 BDD prevalence meta-analyses, AAD and NHS pages, FDA pages, 2 drug labels

This is a reference article, not a price comparison. Peptilyze compares prices of research peptides; it sells nothing and gives no medical advice. Every claim is numbered and listed under Sources.

Key points

  • “Looksmaxxing” means trying to maximise physical attractiveness. In published research the word covers everything from skincare to cosmetic surgery to unapproved injectables [1][2].
  • Researchers who studied a large looksmaxxing forum placed it inside the “manosphere” and argued that it harms the men who take part [1]. That is one qualitative study, not a measure of how many people are harmed.
  • The American Academy of Dermatology (AAD) says these behaviours “may overlap or worsen body dysmorphic disorder” and lists skin complications from home treatments and gray-market injectables [2].
  • Regulators are specific about the riskiest parts: the FDA says not to inject yourself with dermal fillers and lists safety concerns about compounded melanotan II [8][9].
  • The evidence-based end is plain: sunscreen, and approved hair-loss medicines, which are covered in separate articles.

What the word means

Halpin and colleagues, writing in Sociology of Health & Illness in 2025, define it as “maximising one’s physical appearance to attract partners and receive the social benefits that accompany being attractive” [1]. The AAD describes “a rapidly expanding social media trend focused on optimizing physical appearance” [2].

Two terms recur in the literature. “Softmaxxing” refers to lower-intensity practices and “hardmaxxing” to invasive ones; a 2026 oral-surgery paper uses both [3], and the AAD page puts hardmaxxing at orthodontic care, cosmetic surgery, excessive supplements, gray-market injectables and off-label hormones [2].

Where the term comes from

The best-sourced account we opened is the 2025 study above. Its authors say looksmaxxing communities are “part of the manosphere”, a set of male-oriented websites sharing a “red pill” ideology, and that members rate each other on the “PSL scale”, named for three manosphere forums [1]. That ties the vocabulary to those forums.

We could not confirm a first-use date or a founding forum from a reliable news report or academic paper. Search results offered dates from about 2014 to 2015, but they came from meme wikis and blogs, which we do not treat as sources. The same material says the practice reached TikTok and other mainstream platforms in the early 2020s; we could not verify that either. The same study says looksmaxxing is “promoted on many social media platforms” [1]. We leave out the community’s slang and recruiting language on purpose.

The spectrum

Clinicians describe a continuum, not two camps. The table uses the AAD’s framing and our existing articles.

Level Examples named in the sources Regulatory character More detail
Grooming and skincare Skincare, sun protection, tongue-posture “mewing” Mostly consumer products; mewing has no regulatory status Mewing, sunscreen
Prescription and medical Topical retinoids, hair-loss drugs, dermal fillers, orthodontics Prescription, over-the-counter drug or device, depending on product Retinoids, fillers
Surgery Rhinoplasty, jaw and limb-lengthening operations Performed by licensed surgeons Tier-list check
Unregulated Gray-market injectables, melanotan, self-injected filler, self-inflicted facial trauma Unapproved or unlawful to inject at home Melanotan, bone smashing

A viral tier list that ranked 33 of these items is checked item by item in our tier-list analysis.

What researchers have found about the community

The forum study. Halpin et al. analysed 8,072 comments in 2023 from two boards of one looksmaxxing website, 5,327 on self-improvement and 2,745 in a photo-rating forum. The authors report that the site receives 6 million unique visitors per month [1]. They describe users critiquing each other’s faces, being encouraged to change their bodies through surgery or mewing, and being “demoralised”. They say they saw “dozens of instances” of users encouraging suicide [1]. The authors declare no conflicts of interest [1].

The limits matter. The data come from one site and one point in time, the analysis is qualitative, and the authors argue a theoretical case rather than measure harm. It tells us what is said in one forum, not what happens to the average person who looksmaxxes [1].

The social-media analysis. A 2026 cross-sectional study by Grillo et al. tracked online discussion with a social-listening tool and Google Trends. It counted 2,518 mentions of “bonesmashing” over 12 months and found about 98% of that content was male. It concluded that dangerous practices are being normalised through “pseudoscientific” language and community validation [3]. The study measures online talk, not injuries.

Body dysmorphic disorder. BDD is a preoccupation with perceived flaws in appearance that causes distress [5]. We found no study that measured how common BDD is among people who looksmaxx. What exists is clinical commentary. The AAD says the behaviours may overlap or worsen BDD and links them to anxiety, depression, disordered eating, compulsive checking and suicidality, citing a 2025 meta-analysis of social comparison on social media and body image [2]. At least four further 2026 papers on looksmaxxing appear in clinical journals, including one in Pediatrics and one in the Journal of Adolescent Health [4]; we could only read their titles, so we do not report their findings.

For context, a 2025 meta-analysis put BDD prevalence at 24% in plastic-surgery patients and 17% in the general population, using a mix of diagnostic tools [5]. A 2017 meta-analysis of 33 publications found 15.04% in plastic-surgery patients and 12.65% in dermatology patients, with ranges as wide as 2.21% to 56.67% [6]. These numbers describe surgical and dermatology clinics, not this community, and they vary with the screening method.

What dermatologists, surgeons and regulators warn about

The AAD page lists complications seen with home cosmetic practices and experimental injectables: inflammatory reactions, foreign-body granulomas, acne-like eruptions, pigment changes, barrier disruption and dermatitis [2]. The page is undated and carries a 2026 copyright. It offers no formal guideline [2]. A related letter in the Journal of the American Academy of Dermatology on ethical challenges in dermatologic practice was published on 5 May 2026; we read only the record, not the text [13].

The FDA’s dermal-filler page (content current as of 6 July 2023) says fillers are approved for adults 22 or older and should be injected by a licensed provider. In its words, “Do not inject yourself with dermal fillers” [8]. It says no filler is approved for over-the-counter use, and that buying online risks counterfeit or unapproved products. The most serious risk is injection into a blood vessel, which can cause tissue death, vision loss including blindness, and stroke [8].

On unapproved drugs, the FDA’s page on bulk drug substances (current as of 22 April 2026) lists melanotan II among nominations withdrawn from consideration for compounding. It says compounded versions may carry immunogenicity risk and cites published case reports of serious adverse events including melanoma [9]. It says AOD-9604 has reported serious adverse events with unclear causality and that injectable GHK-Cu has limited human data [9]. Our melanotan article and GHK-Cu article cover the regulatory detail. We checked US sources only for this section; UK, EU and German positions were not checked.

What the evidence-based end looks like

The ordinary end of the spectrum is unexciting.

  • Sun protection. The AAD recommends a broad-spectrum sunscreen of SPF 30 or higher [10]. See the sunscreen evidence article.
  • Retinoids. Topical retinoids come in prescription and over-the-counter forms; see retinol versus prescription retinoids and tazarotene versus tretinoin.
  • Hair loss. Finasteride 1 mg is a US prescription product labelled for male pattern hair loss in men only, and is contraindicated in pregnancy [11]. Minoxidil 5% solution is an over-the-counter hair-regrowth product for men, labelled for the crown [12]. See finasteride and topical minoxidil. Both labels were read in the versions listed in Sources.
  • A clinician. Several sources above recommend assessment by a dermatologist or surgeon rather than self-treatment [2][8].

Body image and where help sits

Distress about appearance is common, and clinicians treat it. The NHS describes body dysmorphic disorder as a mental health condition, not vanity, most common in teenagers and young adults and affecting both men and women. It says symptoms can improve with treatment, usually cognitive behavioural therapy, sometimes with an antidepressant, and that a GP is the first contact [7]. This is general information, not a diagnosis. Anyone worried about their own situation can speak to a doctor or mental health professional. The NHS page lists no helpline numbers, so we give none.

Risks and unknowns

  • We found no study of how many people looksmaxx, or of outcomes for participants. The community research we opened is one forum study and one social-listening study [1][3].
  • No study we opened measured BDD in looksmaxxing participants. The prevalence numbers come from clinic populations [5][6].
  • The 2026 clinical papers in Pediatrics, Journal of Adolescent Health, Plastic and Reconstructive Surgery Global Open and others were identified by title only; PubMed returned no abstracts [4].
  • The origin date and first forum of the term are not verified.
  • The AAD page is undated and its author is not listed [2].
  • The NHS BDD page was last reviewed 18 October 2023, with a review due 18 October 2026, and we did not check whether it has been updated since [7].

Frequently asked questions

What does looksmaxxing mean? It means maximising one’s physical attractiveness. The word covers grooming and skincare at one end and surgery, unapproved injectables and self-inflicted facial trauma at the other [1][2].

Where did it start? Academic work ties the vocabulary to manosphere forums [1]. We could not verify an exact date or forum from reliable reporting.

Is looksmaxxing the same as body dysmorphic disorder? No. BDD is a diagnosed mental health condition. The AAD says looksmaxxing behaviours may overlap with or worsen it, but no study we found measured BDD in the community [2][5].

What do doctors say about injecting fillers or peptides at home? The FDA says not to self-inject dermal fillers, and lists safety concerns about compounded melanotan II, including case reports of melanoma [8][9].

Sources

  1. Halpin M, Gosse M, Yeo K, Handlovsky I, Maguire F, Sociology of Health & Illness, “When Help Is Harm: Health, Lookism and Self-Improvement in the Manosphere” (March 2025). https://pubmed.ncbi.nlm.nih.gov/40069550/ (abstract via NCBI E-utilities; full text via PMC 11896937, https://pmc.ncbi.nlm.nih.gov/articles/PMC11896937/). Used for definition, method, quotes, funding statement.
  2. American Academy of Dermatology, “Looksmaxxing and dermatologic complications” (undated, copyright 2026). https://www.aad.org/member/clinical-quality/clinical-care/emerging-diseases/viral-trends/looksmaxxing
  3. Grillo R et al., J Stomatol Oral Maxillofac Surg, “Dangerous trends on social media related to facial esthetics: Analysis of looksmaxxing and its softmaxxing and hardmaxxing practices” (31 Aug 2026). https://pubmed.ncbi.nlm.nih.gov/42674114/
  4. PubMed search “looksmaxxing” (run 2026-11-08, titles only): Konig 2025, Pediatrics 2026 (PMID 42580741), J Adolesc Health 2026 (PMID 42993115), Plast Reconstr Surg Glob Open 2026 (PMID 42719901), and others. https://pubmed.ncbi.nlm.nih.gov/?term=looksmaxxing
  5. Prevalence of Body Dysmorphic Disorder: A Systematic Review and Meta-Analysis, J Cosmet Dermatol (2025). https://pubmed.ncbi.nlm.nih.gov/40200598/
  6. Prevalence of Body Dysmorphic Disorder in Plastic Surgery and Dermatology Patients: A Systematic Review with Meta-Analysis, Aesthetic Plast Surg (2017). https://pubmed.ncbi.nlm.nih.gov/28411353/
  7. NHS, “Body dysmorphic disorder (BDD)” (last reviewed 18 Oct 2023). https://www.nhs.uk/mental-health/conditions/body-dysmorphia/
  8. FDA, “Dermal Fillers (Soft Tissue Fillers)” (content current 6 Jul 2023). https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers
  9. FDA, “Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks” (content current 22 Apr 2026). https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
  10. American Academy of Dermatology, “How to select a sunscreen” (undated, copyright 2026). https://www.aad.org/public/everyday-care/sun-protection/shade-clothing-sunscreen/how-to-select-sunscreen
  11. Organon, Propecia label, DailyMed (version of 14 Oct 2024). https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f904709-65aa-44ce-b144-b4c8a0416e36
  12. Kenvue, Men’s Rogaine Extra Strength label, DailyMed (version of 4 Nov 2024). https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ccaecec5-5348-4b24-9190-5464c50f6d80
  13. Moraga RJ, Rieder E, Zampella JG, J Am Acad Dermatol, “Looksmaxxing and dermatologic practice: Navigating emerging ethical challenges” (letter, 5 May 2026; PubMed record only). https://pubmed.ncbi.nlm.nih.gov/42092609/

This article is information, not medical advice.

More in Analysis